The Solution
ChromaDose will be the latest generation of drug monitoring technology.
An automated desktop device will provide a universal platform that conducts rapid testing with our disposable medicine-specific cartridge.
These hardware components are combined with an easy-to-use software interface and advanced image analysis, that deliver market leading performance in medicine exposure measurement.
​Find out more about our progress.
Technical Advantages
Point-of-care
Small footprint, hermetically sealed and requiring only a mains supply.
Fully automated
From blood sample insertion to medicine exposure readout.
Performance
Internally standardised and calibrated. Sensitive to clinical concentration ranges for both target drug and key metabolite
Scalable
From blood sample insertion to medicine exposure readout.
Rapid
Results within 30-minutes from sample insertion.
Benefits to Care
Enabling earlier medicines optimisation
Doctors will be informed of patient medicine exposure in near real time, supporting timely and agile dose adjustments to safer and more effective levels.
Serving under-represented populations
Generation of medicine exposure information on children with cancer at scale that was previously unavailable or in short supply.
Improving data standards
Standardisation of the drug monitoring process will reduce site-to-site variation and handling errors. This generates data libraries which are easy to compare and can be used to predict accurate doses.
Reducing costs to healthcare
​
ChromaDose offers up to a 75-fold cost reduction to current drug monitoring solutions. This is in addition to a reduced inpatient healthcare burden from improved health outcomes and reduced adverse drug-related events.
Improving process ownership
Point-of-care access and simple analysis enables patients, nurses and doctors to own the treatment monitoring process. This is key for improving patient experiences and supporting widespread use.
Wider-scale drug monitoring and multi-patient benefit
​
Versatility allows for expansion beyond the anthracycline drug class. Satellite devices bring drug monitoring to the patient bedside irrespective of location.